Atlas Trials

mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line

Clinical trial NCT03464968 · COMPLETED

Trial details

NCT number
NCT03464968
Sponsor
Seoul National University Bundang Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Biliary Cancer Metastatic
Start date
2015-07-29
Primary completion
2020-02-10
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.